MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. WEAV
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Weave Communications (WEAV) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Weave Communications
NYSE•Healthcare•Health Information Services
$7.34+0.01(<0.01%)Market open
Market Cap
$580.52M
P/S
2.3x
P/B
6.8x

Weave Communications, Inc. operates an AI-powered patient communications, engagement, and payments platform for small and medium-sized healthcare businesses. It offers AI-receptionist; Unified Phone Number; Customized Phone System, a smarter phone system to identify whether incoming calls are from new or current patients, provide information at every call, and manage heavy call times; Softphones to make and receive calls from anywhere with an internet connection; Text Messaging and SMS response assistant; Missed Call Text that allows practices to respond when a call is missed; Missed Text Auto-Reply that replies to patient text messages by automatically responding to messages received outside of a practice's normal operating hours; Team Chat, a group messaging solution; and Weave Mobile App. It also provides Weave Reviews and Respond Assistant to request, collect, monitor, and respond to reviews; Weave Email Marketing and Email Assistant to create professional emails; Text Connect to interact with their patients online directly through their websites; and Weave Payments, a payment processing solution. The company provides Weave Digital Forms to collect patient information; Online Scheduling that allows patients to request appointments from the practice's website, send automatic scheduling reminders, and personalize each reminder for the patient; Insurance Eligibility, an insurance tool; Insurance Verification; Practice Analytics that provides real-time data on patient retention, appointment scheduling, treatment acceptance rates, and revenue generation; Call Intelligence; and Weave Enterprise for multi-location healthcare practices comprising dental service organizations, vision, veterinary, and medical groups. The company was formerly known as Recall Solutions, LLC and changed its name to Weave Communications, Inc. in October 2015. Weave Communications, Inc. was founded in 2008 and is headquartered in Lehi, Utah.

D

How this company scores

WeakMetricSide Score: 50/100

Grade capped at D — Interest coverage below 1× (-12.8x) — earnings cannot cover interest. Strongest: Growth (18/25); weakest: Balance Sheet & Red Flags (7/25).

Profitability17/25
Growth18/25
Balance Sheet & Red Flags7/25
Cash & Earnings Quality8/25
Strengths
Growing revenueLong cash runwayProfit converts from growthConsistent growth
Grade capped at D
  • Interest coverage below 1× (-12.8x) — earnings cannot cover interest.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/S · 2.3x5y range 1.1x – 5.7x
P/S 2.3x · near its 17-quarter median

Currently near its 17-quarter median.

P/B · 6.8x5y range 2.2x – 17.3x
P/B 6.8x · near its 19-quarter median

Currently near its 19-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

FCF consistently trails net income (avg -0.8x) — earnings may be inflated by non-cash items or aggressive accounting.

Price & Volume
Market Cap $580.52M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue
$257.79M
7Q
Q. Revenue
$67.54M
7Q
TTM EBITDA
$-9.31M
3Q
TTM Op. Income
$-21.51M
3Q
Q. Op. Income
$-4.39M
57%
TTM Net Income
$-20.54M
3Q
Q. Net Income
$-4.26M
51%
EPS
$-0.05
55%
Shares Out.
$79.63M
7Q
$257.79M in TTM revenue grew 16.7% YoY, reaching $67.54M last quarter. TTM EBITDA of $-9.31M and TTM operating income of $-21.51M show growth is flowing through to the bottom line. However, net income is negative at $20.54M — growth is not yet reaching the bottom line. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin
72.0%
2Q
EBITDA Margin
-1.8%
86%
Op. Margin
-6.5%
63%
Net Margin
-6.3%
58%
Op. margin of -6.5% is up 10.9% YoY — cost efficiency is improving. Net margin at -6.3% and gross margin of 72.0% show how much of each revenue dollar survives to profit. Over the past year, operating margin is up 63% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio
N/A
P/S Ratio
2.3x
21%
P/B Ratio
6.8x
15%
P/S of 2.3x and P/B of 6.8x.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets
$208.59M
2%
Cash
$47.63M
7%
Long-Term Debt
N/A
Book Value
$84.97M
3Q
D/E Ratio
N/A
Debt/EBITDA
N/A

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$10.24M
88%
TTM Free Cash Flow
$14.29M
1%
FCF Margin
5.5%
15%
FCF / Net Income
-0.7
45%
TTM FCF of $14.29M on $10.24M in operating cash flow. The FCF / Net Income ratio of -0.7x means the business consumes cash — it is not yet self-funding. Over the past year, free cash flow is down 1% — an improving trend.

Related Stocks in Healthcare

View Sector
LLY$938.28B
Lilly (Eli)
Drug Manufacturers - General
JNJ$586.47B
Johnson & Johnson
Drug Manufacturers - General
ABBV$411.57B
AbbVie
Drug Manufacturers - General
MRK$303.29B
Merck & Co.
Drug Manufacturers - General
UNH$249.74B
UnitedHealth Group
Healthcare Plans
TMO$203.77B
Thermo Fisher Scientific
Diagnostics & Research
AMGN$201.34B
Amgen
Drug Manufacturers - General
GILD$191.61B
Gilead Sciences
Drug Manufacturers - General

Cash Burn

Watch

FCF turned negative in 2 of the last 8 quarters — occasional cash consumption.

Share Dilution

Red Flag

Shares outstanding increased 10.6% — significant dilution, likely from stock compensation or capital raises.